-
AstraZeneca to invest $2 billion as part of US manufacturing push
21 Nov 2025 19:29 GMT
… investment marks the fourth in AstraZeneca's larger expansion … a full listing of its shares on the New York … for millions of Americans. AstraZeneca's Frederick facility currently … therapies. These are used across AstraZeneca's portfolio of …
-
Roche oral drug shown to keep breast cancer at bay, boosting shares
18 Nov 2025 10:39 GMT
… , boosting the company's shares and underpinning its traditional credentials … market opportunity has also attracted AstraZeneca, which is developing rival compound …
-
AstraZeneca Pharma India Ltd and Sun Pharma partner to help patients living with Hyperkalaemia in India
18 Nov 2025 01:58 GMT
… the therapy as Gimliand®. AstraZeneca will retain the intellectual property … Country President & Managing Director AstraZeneca Pharma India Limited said, … better patient outcomes nationwide.
Shares of AstraZeneca Pharma India Limited was last …
-
Novo Nordisk (NYSE: NVO) Stock Price Prediction and Forecast 2025-2030 (Nov 2025)
22 Nov 2025 02:48 GMT
… Nordisk buying Corvidia Therapeutics from AstraZeneca for its heart disease treatments … , seven of them recommend buying shares. Their consensus 12-month target …
-
Eli Lilly becomes first drugmaker to hit $1 trillion in market value
22 Nov 2025 01:41 GMT
… developing drugs for obesity. Shares, worth under $100 as … diabetes drug Mounjaro, which shares the same active ingredient, … share calculations. If those shares were similarly excluded from determining … ’s and Merck’s. AstraZeneca, which booked more revenue …
-
Graft Versus Host Disease (GvHD) Treatment Market Trends, Strategies and Investment Opportunities 2025-2030 - CAR-T and Cell Therapy Advancements Generate New Demand for GvHD Management Solutions - ResearchAndMarkets.com
21 Nov 2025 18:45 GMT
… forecast period?
How will market shares for different regions and segments … :
AbbVie Inc.
Astellas Pharma Inc.
AstraZeneca plc
Bristol Myers Squibb
Eli …
-
Anticancer Drugs Market Set to Expand at 9.14% CAGR, Reaching USD 401.32 Billion by 2034
21 Nov 2025 13:00 GMT
… include Roche, Novartis, Pfizer, AstraZeneca, and Bristol-Myers Squibb. Clinical … a more convenient administration option.
AstraZeneca Key Offerings:
Tagrisso – EGFR … wise market breakdowns, regional performance shares, detailed company profiles, annual …
-
Falling stock markets and high shop prices hit US consumer confidence; rate cut hopes lift Wall Street – as it happened
21 Nov 2025 07:15 GMT
… December has reduced.
Share
AstraZeneca announces $2bn Maryland investment … news.
Anglo-Swedish drugmaker AstraZeneca is to invest $2bn … marks the fourth in AstraZeneca’s larger expansion plan, … next month have pushed shares higher on Wall Street …
-
ASX health stocks slide but Island surges
21 Nov 2025 05:51 GMT
… and Bristol Myers Squibb, and AstraZeneca placing its tenth order.
Pfizer … this article.
Scott Power owned shares in EBR and CC5 at … underwriter to the placement of shares for EBR Systems Ltd in …
-
IonQ's Big Market Potential Is Priced Into Its Steep Valuation: Analyst
20 Nov 2025 19:34 GMT
IonQ, Inc. (NYSE:IONQ) shares slipped on Thursday as a … cites collaborations with Hyundai, AFRL, AstraZeneca, EPB and Ansys as important … current levels.
Price Action: IONQ shares were trading lower by 8 …
About
© 1995-2025